These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 2897480

  • 1. [Mechanism of recurrence and relapse in peptic ulcer after drug therapy; gastric juice and gastric acid secretion].
    Nakaizumi A, Iishi H, Tatsuta M, Okuda S.
    Nihon Rinsho; 1988 Jan; 46(1):102-6. PubMed ID: 2897480
    [No Abstract] [Full Text] [Related]

  • 2. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
    Gorshkov VA.
    Klin Med (Mosk); 2002 Jan; 80(9):66-70. PubMed ID: 12416232
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Drug therapy for preventing peptic ulcer recurrence.
    Sutherland JE.
    Am Fam Physician; 1986 Nov; 34(5):141-4. PubMed ID: 2877559
    [Abstract] [Full Text] [Related]

  • 7. Histamine H2-receptor antagonists.
    Keithley JK.
    Nurs Clin North Am; 1991 Jun; 26(2):361-73. PubMed ID: 1675461
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD, Schubert ML.
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
    Miagkova LP, Grebenev AL, Kkhorshed AM.
    Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacologic control of gastric acid secretion in peptic ulcer.
    Konturek SJ.
    Mt Sinai J Med; 1983 Mar; 50(6):457-67. PubMed ID: 6141524
    [No Abstract] [Full Text] [Related]

  • 13. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K, Kato S, Yamamoto H, Okabe S.
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [Abstract] [Full Text] [Related]

  • 14. [Various problems on refractory peptic ulcers; ulcers resistant to therapy with H2-receptor antagonists--therapeutic countermeasures].
    Itoh M.
    Nihon Rinsho; 1988 Jan; 46(1):140-5. PubMed ID: 2897483
    [No Abstract] [Full Text] [Related]

  • 15. Current concepts in clinical therapeutics: peptic ulcer disease.
    Siepler JK, Mahakian K, Trudeau WT.
    Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
    [Abstract] [Full Text] [Related]

  • 16. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders].
    Tani N, Miwa T.
    Nihon Rinsho; 1988 Jan; 46(1):12-7. PubMed ID: 2897482
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Famotidine--a new histamine H2 receptor blockader].
    Grigor'ev PIa, Isakov VA, Iakovenko EP, Davydov SM, Vasil'eva ZI.
    Klin Med (Mosk); 1991 Apr; 69(4):23-8. PubMed ID: 1865643
    [No Abstract] [Full Text] [Related]

  • 19. [Perspectives in the drug therapy of peptic ulcer].
    Kamada T, Sato N, Kawano S.
    Nihon Rinsho; 1988 Jan; 46(1):7-11. PubMed ID: 2897487
    [No Abstract] [Full Text] [Related]

  • 20. Antacids in the treatment of peptic ulcer: are they obsolete?
    Anand AC.
    Trop Gastroenterol; 1990 Jan; 11(1):25-9. PubMed ID: 1972600
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.